Company intelligence / Profile preview

Arrow Pharmaceuticals

Bhaktapur, Nepal

Ownership: Private
Development stage: Other

Overview

The company manufactures and markets affordable, high-quality medicines, including a dedicated portfolio of cephalosporin antibiotics, serving unmet prescription demand in Nepal. No clinical development or trials reported; all products are commercialized generics

Therapeutic areas: Infectious DiseasesPulmonology
Modalities: Small moleculeCephalosporin (antibiotic)Generic medicines
Industry: Biotech

Beyond the preview

Go deeper on Arrow Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Arrow Pharmaceuticals.

Explore the full profile